Association Between Zinc Deficiency and Adverse Outcomes in Patients with Dementia: A Matched Cohort Study

Why It Matters

Zinc status emerges as a potentially modifiable risk factor that can help clinicians identify dementia patients at heightened short‑term mortality and infection risk, informing monitoring and nutritional strategies.

Key Takeaways

• Zinc deficiency raises 1‑year mortality in dementia patients.
• Deficient patients face higher sepsis and ICU admission risks.
• Severe deficiency (<50 µg/dL) nearly triples sepsis risk.
• Associations weaken after the first year of follow‑up.
• Findings suggest zinc as a short‑term prognostic marker.

Pulse Analysis

Dementia’s growing prevalence places a premium on identifying reversible contributors to its high mortality. Zinc, an essential trace element for immune competence and inflammation control, is frequently low in older adults and institutionalized patients. Nutritional surveys consistently report suboptimal zinc levels among those with cognitive decline, reflecting reduced intake, malabsorption, and increased metabolic demand. Recognizing zinc deficiency as more than a laboratory oddity reframes it as a potential early warning signal for clinicians managing complex dementia cases.

The TriNetX analysis of over 2,400 matched patients quantifies that risk. Within one year, zinc‑deficient individuals faced a 1.54‑fold increase in all‑cause death and markedly higher odds of sepsis (HR 1.76) and ICU admission (HR 1.67). A clear dose‑response emerged: patients with severe depletion (<50 µg/dL) suffered a 1.85‑fold mortality rise and a 2.9‑fold surge in sepsis. Notably, these hazards faded after the first year, indicating that low zinc may signal an acute vulnerability rather than a chronic determinant, and highlighting a window for intervention.

Clinically, the findings argue for routine zinc screening in dementia care, especially before hospital discharge or during acute illness. While the observational design precludes causality, the moderate E‑value suggests that unmeasured confounding would need to be strong to nullify the association. Prospective trials are now essential to test whether targeted zinc supplementation can lower infection rates and improve survival. Until such evidence emerges, integrating zinc assessment into comprehensive geriatric evaluations could refine risk stratification and guide personalized nutritional support, potentially mitigating the excess morbidity that burdens patients, families, and health systems.